Cargando…
Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access
Cellular therapies and other regenerative medicines are emerging as potentially transformative additions to modern medicine, but likely at a staggering financial cost. Public health care systems’ budgets are already strained by growing and aging populations, and many private insurer's budgets a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689744/ https://www.ncbi.nlm.nih.gov/pubmed/28749065 http://dx.doi.org/10.1002/sctm.16-0487 |